About the Company
We do not have any company description for INVO Bioscience, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
24
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $INVO News
Why Invo BioScience Stock Is Soaring Today
INVO BioScience, Inc. (NASDAQ:INVO) shares are trading higher Wednesday after the company reported its fourth-quarter ...
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter ...
INVO Bioscience, Inc. (INVO) Stock Price, News, Quote & History - Yahoo Finance
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
Clinic revenue increased 519% to $1,362,938, compared to $220,253. All reported clinic revenue is derived from the Company's INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin ...
INVO Bioscience Inc (INVO) Shares Decline Despite Market Challenges
The net margin for INVO Bioscience Inc stands at -4.83. The total capital return value is set at -0.55. Equity return is now at value -1061.05, with -72.92 for asset returns.
INVO BioScience, Inc. Common Stock (INVO)
Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...
INVO Bioscience Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
INVO BioScience Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...